SEARCH
Leading a Time of Transformation
for Targeted Radiation Therapy
ASTRO 2019 | Booth 4205
September 15 - 18, 2019 | Chicago, IL
ProFound AI
Discover the ProFound impact of artificial intelligence for digital breast tomosynthesis
FDA Cleared, CE Mark, Health Canada Licensed
Discover the Xoft Electronic Brachytherapy (eBx) System
Explore Breakthrough Technology Delivering Excellent Results
<
>
Who is iCAD?
iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. We work passionately to provide precise, powerful healthcare solutions expertly engineered to optimize operational efficiency, clinician confidence and patient outcomes.
Recent News
September 16, 2019
iCAD Exhibiting New Updates and Enhanced Xoft Platform at ASTRO Including Single-Fraction IORT Solution for the Treatment of Early-Stage Breast Cancer
September 10, 2019
iCAD’s ProFound AI Reader Study Published in Radiology: Artificial Intelligence
September 4, 2019
iCAD’s ProFound AI Wins “Best New Radiology Solution” in 2019 MedTech Breakthrough Awards
August 1, 2019
iCAD Reports Second Quarter 2019 Financial Results
July 29, 2019
iCAD to Report Second Quarter 2019 Financial Results On Thursday, August 1
» View All News »
CONNECT
© 2018, iCAD Inc. All rights reserved. iCAD, the iCAD logo,, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.
